You are here » Home » Companies » Company Overview » Syncom Formulations (India) Ltd

Syncom Formulations (India) Ltd.

BSE: 524470 Sector: Health care
NSE: N.A. ISIN Code: INE312C01025
BSE LIVE 15:40 | 15 Dec 1.89 0.05
(2.72%)
OPEN

1.89

HIGH

1.99

LOW

1.81

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 1.89
PREVIOUS CLOSE 1.84
VOLUME 835355
52-Week high 2.50
52-Week low 1.17
P/E 15.75
Mkt Cap.(Rs cr) 148
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1.89
CLOSE 1.84
VOLUME 835355
52-Week high 2.50
52-Week low 1.17
P/E 15.75
Mkt Cap.(Rs cr) 148
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd

Incorporated as a private limited company in 1988, Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar, Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda, Vijay Kumar Bankda and Ajay Kumar Bankda. In addition to pharmaceutical formulations ...> More

Syncom Formulations (India) Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   148
EPS - TTM () [*S] 0.12
P/E Ratio (X) [*S] 15.75
Face Value ()   1
Latest Dividend (%)   2.00
Latest Dividend Date 21 Sep 2017
Dividend Yield (%) 1.06
Book Value / Share () [*S] 1.52
P/B Ratio () [*S] 1.24
[*C] Consolidated     [*S] Standalone    

Syncom Formulations (India) Ltd - Financial Results

Particulars ( cr) Sep 2017 Sep 2016 % Chg
Net Sales 38.92 47.19 -17.52
Other Income 1.12 0.94 19.15
Total Income 40.03 48.12 -16.81
Total Expenses 36.23 42.88 -15.51
Operating Profit 3.8 5.25 -27.62
Net Profit 2.01 2.97 -32.32
Equity Capital 78.07 78.07 -
> More on Syncom Formulations (India) Ltd Financials Results

Syncom Formulations (India) Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Krebs Biochem 112.15 1.95 154.09
Nutraplus India 45.00 6.01 153.45
Lactose (India) 155.40 -2.88 150.43
Syncom Formul. 1.89 2.72 147.55
Aarey Drugs 68.60 12.64 137.75
Bal Pharma 96.75 1.79 137.09
Venus Remedies 100.15 0.30 123.59
> More on Syncom Formulations (India) Ltd Peer Group

Syncom Formulations (India) Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 38.98
Banks/FIs 0.00
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 52.24
Custodians 0.00
Other 8.78
> More on Syncom Formulations (India) Ltd Share Holding Pattern

Syncom Formulations (India) Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -12.90% NA 0.64% 0.66%
1 Month 9.88% NA 2.14% 2.13%
3 Month 28.57% NA 3.69% 2.46%
6 Month 18.87% NA 7.68% 7.88%
1 Year -12.09% NA 26.18% 26.73%
3 Year -76.46% NA 22.49% 25.71%

Syncom Formulations (India) Ltd - STOCK STRENGTH

Today's Low/High 1.81
1.99
Week Low/High 1.77
2.00
Month Low/High 1.57
2.00
YEAR Low/High 1.17
3.00
All TIME Low/High 0.14
15.00